Literature DB >> 7523481

TSH receptor gene expression in retroocular fibroblasts.

M Mengistu1, Y G Lukes, E V Nagy, H B Burch, F E Carr, S Lahiri, K D Burman.   

Abstract

RNA was isolated from fibroblasts from the retroocular area, from endomysial fibroblasts obtained from orbital lateral rectus muscle, and from abdominal skin fibroblasts. The RNA was reverse transcribed into cDNA which was then used as a template for PCR with primers encompassing a portion (nucleotides 989-1235) of the extra-cellular domain of the human TSH receptor (hTSH-R). A definite 247 BP product was detected from fibroblast RNA by ethidium bromide staining, and was confirmed by hybridization with labelled hTSH-R cDNA. The product had homology with the known TSH-R cDNA. These studies indicate that human fibroblasts can express hTSH-R, and they suggest that a cross reactive immunologic response between anti-hTSH-R and these fibroblast TSH receptors may play a role in the genesis of Graves' ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523481     DOI: 10.1007/BF03347732

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy.

Authors:  A E Heufelder; R S Bahn
Journal:  Exp Clin Endocrinol       Date:  1992

Review 2.  The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.

Authors:  Y Nagayama; B Rapoport
Journal:  Mol Endocrinol       Date:  1992-02

Review 3.  Thyroid-associated ophthalmopathy--a model for the association of organ-specific autoimmune disorders.

Authors:  J R Wall; M Salvi; N F Bernard; A Boucher; D Haegert
Journal:  Immunol Today       Date:  1991-05

Review 4.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

5.  Molecular cloning of the thyrotropin receptor.

Authors:  M Parmentier; F Libert; C Maenhaut; A Lefort; C Gérard; J Perret; J Van Sande; J E Dumont; G Vassart
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

6.  Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease.

Authors:  A E Heufelder; J R Goellner; B E Wenzel; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

7.  Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle.

Authors:  R Paschke; R Elisei; G Vassart; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

8.  Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy.

Authors:  A E Heufelder; T J Smith; C A Gorman; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

9.  Thyrotropin receptor in non-thyroid tissues.

Authors:  T Endo; M Ohno; S Kotani; K Gunji; T Onaya
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

10.  Cloning, sequencing and expression of human TSH receptor.

Authors:  M Misrahi; H Loosfelt; M Atger; S Sar; A Guiochon-Mantel; E Milgrom
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

View more
  16 in total

Review 1.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

2.  Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.

Authors:  Ji Sung Han; Hyung Suk Seo; Young Hen Lee; Hwa Lee; Sang-Il Suh; Eun-Kee Jeong; Nabraj Sapkota; Ki Joon Kim
Journal:  Neuroradiology       Date:  2016-11-14       Impact factor: 2.804

3.  High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.

Authors:  P E Macchia; M Bagattini; G Lupoli; M Vitale; G Vitale; G Fenzi
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

4.  Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.

Authors:  Seema Kumar; Alexey Leontovich; Michael J Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

5.  Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.

Authors:  S L Wu; C S Yang; H J Wang; C L Liao; T J Chang; T C Chang
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

6.  A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Authors:  Seema Kumar; Reagan Schiefer; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

7.  Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary.

Authors:  Su-Chin Sun; Pei-Jen Hsu; Fang-Ju Wu; Sheng-Hsiang Li; Chung-Hao Lu; Ching-Wei Luo
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

8.  Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells.

Authors:  S L Wu; T C Chang; T J Chang; Y F Kuo; Y L Hsiao; C C Chang
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

Review 9.  Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

10.  Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.

Authors:  Seema Kumar; Michael J Coenen; Philipp E Scherer; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.